Double-Stranded RNA-Dependent Protein Kinase Is Involved in 2-Methoxyestradiol—Mediated Cell Death of Osteosarcoma Cells
Open Access
- 1 January 2007
- journal article
- research article
- Published by Oxford University Press (OUP) in Journal of Bone and Mineral Research
- Vol. 22 (1) , 29-36
- https://doi.org/10.1359/jbmr.060914
Abstract
We studied the involvement of interferon‐regulated, PKR on 2‐ME–mediated actions in human osteosarcoma cells. Our results show that PKR is activated by 2‐ME treatment and is necessary for 2‐ME–mediated induction of osteosarcoma cell death. Introduction: Osteosarcoma is the most common primary bone tumor and most frequently develops during adolescence. 2‐Methoxyestradiol (2‐ME), a metabolite of 17β‐estradiol, induces interferon gene expression and apoptosis in human osteosarcoma cells. In this report, we studied the role of interferon‐regulated double‐stranded (ds)RNA‐dependent protein kinase (PKR) protein on 2‐ME–mediated cell death in human osteosarcoma cells. Materials and Methods: Western blot analyses were used to measure PKR protein and phosphorylation levels. Cell survival and apoptosis assays were measured using trypan blue exclusion and Hoechst dye methods, respectively. A transient transfection protocol was used to express the dominant negative PKR mutants. Results and Conclusions: PKR was increased in 2‐ME–treated MG63 cells, whereas 17β‐estradiol, 4‐hydroxyestradiol, and 16α‐hydroxyestradiol, which do not induce cell death, had no effect on PKR protein levels. Also, 2‐ME treatment induced PKR kinase activity as indicated by increased autophosphorylation and phosphorylation of the endogenous substrate, eukaryotic initiation factor (eIF)‐2α. dsRNA poly (I).poly (C), an activator of PKR protein, increased cell death when osteosarcoma cells were treated with a submaximal concentration of 2‐ME. In contrast, a serine‐threonine kinase inhibitor SB203580 and a specific PKR inhibitor 2‐aminopurine (2‐AP) blocked the 2‐ME–induced cell death in MG63 cells. A dominant negative PKR mutant protein conferred resistance to 2‐ME–induced cell death to MG63 osteosarcoma and 2‐ME–mediated PKR regulation did not require interferon gene expression. PKR protein is activated in cell free extracts by 2‐ME treatment, resulting in autophosphorylation and in the phosphorylation of the substrate eIF‐2α. We conclude from these results that PKR is regulated by 2‐ME independently of interferon and is essential for 2‐ME–mediated cell death in MG63 osteosarcoma cells.Keywords
This publication has 64 references indexed in Scilit:
- Down-Regulation of p53 by Double-Stranded RNA Modulates the Antiviral ResponseJournal of Virology, 2005
- Interferons and ApoptosisJournal of Interferon & Cytokine Research, 2003
- Implications for RNase L in Prostate Cancer BiologyBiochemistry, 2003
- Human breast cancer cells contain elevated levels and activity of the protein kinase, PKROncogene, 2000
- PKR; a sentinel kinase for cellular stressOncogene, 1999
- PKR, apoptosis and cancerThe International Journal of Biochemistry & Cell Biology, 1999
- Superinduction of wild-type p53 protein after 2-methoxyestradiol treatment of Ad5p53-transduced cells induces tumor cell apoptosisOncogene, 1998
- Malignant transformation by a mutant of the IFN-inducible dsRNA-dependent protein kinaseScience, 1992
- Activation of double-stranded RNA-dependent kinase (dsl) by the TAR region of HIV-1 mRNA: A novel translational control mechanismCell, 1989
- The excretion of five different 2-hydroxyoestrogen monomethyl ethers in human pregnancy urineThe Journal of Steroid Biochemistry and Molecular Biology, 1976